top of page

EU-GMP designed manufacturing & extraction facility for sale in Southern Italy

State-of-the-art manufacturing and extraction facility in Southern Italy, fully equipped for industrial processing, laboratory analysis, packaging, and secure storage. Ideal for cannabinoid extraction, R&D, or industrial biotech applications. Available for outright sale.

Listing ID:

31615780783

Licence(s) Held:

N/A

Italy flag with cannabis leaves for an EU GMP extraction facility sale.

Seeking outright sale of the land, buildings and equipment. Inquire for more information.

Listing Details:

  • ~3,800+ m² state-of-the-art operational facilities constructed to EU-GMP standards, strategically located in Southern Italy within a well-established industrial zone.

  • Fully turnkey setup with design and infrastructure to meet EU-GMP certification and pharmaceutical-grade standards

  • Recent construction completed in 2021; facility is in excellent condition and has never been commercially operated

  • Land size totals 9,500 m², including green space, parking, and asphalted areas

  • Facility includes offices (600 m²), warehouse and pellet storage (721 m²), and production/lab/office/mezzanine/HVAC areas (approx. 2,934 m²)

  • External greenhouse for primary processing measures 1,080 m² (270 m² considered commercial area)

  • Purpose-built for extraction and processing of active ingredients for pharmaceutical, nutraceutical, and cosmetic applications

  • Also ideally suited for cannabinoid extraction, industrial biotech, and R&D use

  • Facility features include extraction and processing areas, packaging zones, multiple laboratory spaces, secure storage, shipping zones, office areas, and support rooms

  • ~€4 million value for land and building based on recent third-party appraisal

  • ~€7.3 million invested in specialized equipment and systems

  • Equipment includes KPD1500, Capna, and KD10 extraction systems, distillation units, rotavapor, HVAC system, photovoltaic solar array, Agilent LC/MS system, silos, office equipment, and vehicles

  • Facility is equipped with climate control, energy systems, solar panels, and electrical transformers

  • Buyer may benefit from available tax loss carryforwards associated with the facility

  • Ownership is seeking an outright sale of the land, buildings, and equipment as a package

31615780783

Inquiry Form

Thanks for submitting! We have received your message and will get back to you within 24 hours. Until then, you can send an email to info@hydeadvisory.com

Contact-us-deal

NEW CANNABIS BUSINESSES FOR SALE

See the latest cannabis business listings on the market including dispensaries, cultivation facilities, greenhouses, labs, and more. If you're looking to invest, acquire, or expand, these business opportunities provide the perfect starting point to grow your footprint in the cannabis industry.

Cannabis New/Featured Business Listing - Merger & Acquisition

36324927098

Licensed Colombian medical cannabis platform targeting EU pharmaceutical market seeks $3M equity partner

Cannabis New/Featured Business Listing - Merger & Acquisition

Premium, fully licensed Colombian cannabis cultivation platform offering pharmaceutical-grade production at industry-leading costs, with secured European market access and scalable growth potential

Cannabis New/Featured Business Listing - Merger & Acquisition

38939049737

4,800 sq ft licensed, micro-cultivation facility in AB for $500k

Cannabis New/Featured Business Listing - Merger & Acquisition

Opportunity to acquire a turnkey, fully built, turnkey 4,800 sq ft micro-cultivation facility in AB, offered at a significant discount to replacement cost

Cannabis New/Featured Business Listing - Merger & Acquisition

29345918591

State-of-the-art, ~130,000 sq. ft. production facility with 20.5 tonnes annual capacity and & EU-GMP designed processing hub

Cannabis New/Featured Business Listing - Merger & Acquisition

Opportunity to acquire a custom-designed, ~130,000 sq. ft. turnkey production asset including 84,000 square feet of canopy designed for pharmaceutical-grade output. This unique opportunity allows for a clean-slate acquisition of world-class infrastructure providing an immediate entry point into the global medicinal and premium international markets.

bottom of page